HomeLive Vaccine Indicated For Prevention Of Zaire Ebolavirus InLive Vaccine Indicated For Prevention Of Zaire Ebolavirus In + Ansuvimab

Does Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In Interact with Ansuvimab?

Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In and Ansuvimab have a moderate drug interaction according to U.S. FDA drug labeling data. EBANGA may reduce the efficacy of live vaccine. Avoid concurrent administration during EBANGA treatment; interval between administration should follow current vaccination guidelines. The mechanism involves ebanga may inhibit replication of live vaccine virus. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ansuvimab Class
Zaire Ebolavirus Glycoprotein-directed Antibody
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In and Ansuvimab occurs because ebanga may inhibit replication of live vaccine virus. Clinically, this means ebanga may reduce the efficacy of live vaccine. avoid concurrent administration during ebanga treatment; interval between administration should follow current vaccination guidelines. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In and your doctor is considering prescribing Ansuvimab (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In+💊 Ansuvimab(Ebanga)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Zaire Ebolavirus Glycoprotein-directed Antibody
Source
NLP:ansuvimab

What this means in plain English

EBANGA may reduce the efficacy of live vaccine. Avoid concurrent administration during EBANGA treatment; interval between administration should follow current vaccination guidelines.

What the FDA label says

"EBANGA may inhibit replication of live vaccine virus"

📖 Source: NLP:ansuvimab

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Live Vaccine Indicated For Prevention Of Zaire Ebolavirus In and Ansuvimab against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.